Key Insights

Highlights

Treatment Research

5 treatments under study, led by Evaluation Of Clinical Outcome

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06374693Not ApplicableRecruitingPrimary

Investigating the Tolerability and Feasibility of tVNS Following aSAH

NCT02915380Unknown

Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage

Showing all 2 trials

Research Network

Common Treatments

  • Evaluation Of Clinical Outcome1
  • Evaluation Of Pituitary Endocrine Function1
  • Evaluation Of Neuropsychological Function1
  • Sham Transcutaneous Vagus Nerve Stimulation1
  • Transcutaneous Vagus Nerve Stimulation1

Active Sponsors

  • Cambridge University Hospitals NHS Foundation Trust1
  • Dr. Rita Bertuetti1
  • Sheffield Teaching Hospitals NHS Foundation Trust1

Top Investigators

Related Conditions

  • Thyroid Disfunction1
  • Pituitary Disfunction1

Activity Timeline